Reactivation of mitotic arrest upon targeting TACC3 restores immunogenic cell death and T-DM1 response in HER2-positive breast cancer

被引：1
|
作者：
Saatci, Ozge
Gedik, Mustafa Emre
Oberholtzer, Nathaniel
Uner, Meral
Akbulut, Ozge
Cetin, Metin
Aras, Mertkaya
Ibis, Kubra
Caliskan, Burcu
Banoglu, Erden
Wiemann, Stefan
Uner, Aysegul
Aksoy, Sercan
Mehrotra, Shikhar
Sahin, Ozgur
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB275
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB275
引用
收藏
页数：2
相关论文
共 50 条
  • [41] T-DM1 as a New Treatment Option for Patients with Metastatic HER2-positive Breast Cancer in Clinical Practice
    Michel, Laura L.
    Bermejo, Justo Lorenzo
    Gondos, Adam
    Marme, Frederik
    Schneeweiss, Andreas
    ANTICANCER RESEARCH, 2015, 35 (09) : 5085 - 5090
  • [42] Meta-analysis of the clinical efficacy and safety of T-DM1 in the treatment of HER2-positive breast cancer
    Liu, Furong
    Li, Yuehua
    Yang, Dinghua
    Tang, Li
    Yang, Qian
    Jiang, Majiao
    Tian, Leilei
    An, Jingjing
    INDIAN JOURNAL OF CANCER, 2024, 61 (01) : 146 - 155
  • [43] Delayed neurotoxicity in HER2-positive breast cancer: a case series on combined SRS and T-DM1 treatment
    Turna, Menekse
    Caglar, Hale Basak
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [44] Tumor Extrinsic Factors Mediate Primary T-DM1 Resistance in HER2-Positive Breast Cancer Cells
    Endo, Yukinori
    Wu, Wen Jin
    CANCERS, 2021, 13 (10)
  • [45] Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases
    William Jacot
    Elvire Pons
    Jean-Sébastien Frenel
    Séverine Guiu
    Christelle Levy
    Pierre Etienne Heudel
    Thomas Bachelot
    Véronique D’Hondt
    Amélie Darlix
    Nelly Firmin
    Gilles Romieu
    Simon Thezenas
    Florence Dalenc
    Breast Cancer Research and Treatment, 2016, 157 : 307 - 318
  • [46] Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)
    Mileva, Magdalena
    de Vries, Elisabeth G. E.
    Guiot, Thomas
    Wimana, Zena
    Deleu, Anne-Leen
    Schroder, Carolien P.
    Lefebvre, Yolene
    Paesmans, Marianne
    Stroobants, Sigrid
    Huizing, Manon
    Aftimos, Philippe
    Tol, Jolien
    Van der Graaf, Winette T. A.
    Oyen, Wim J. G.
    Vugts, Danielle J.
    van Oordt, C. Willemien van der Houven
    Brouwers, Adrienne H.
    Piccart-Gebhart, Martine
    Flamen, Patrick
    Gebhart, Geraldine
    NPJ BREAST CANCER, 2024, 10 (01)
  • [47] Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)
    Magdalena Mileva
    Elisabeth G. E. de Vries
    Thomas Guiot
    Zéna Wimana
    Anne-Leen Deleu
    Carolien P. Schröder
    Yolene Lefebvre
    Marianne Paesmans
    Sigrid Stroobants
    Manon Huizing
    Philippe Aftimos
    Jolien Tol
    Winette T. A. Van der Graaf
    Wim J. G. Oyen
    Danielle J. Vugts
    C. Willemien Menke-van der Houven van Oordt
    Adrienne H. Brouwers
    Martine Piccart-Gebhart
    Patrick Flamen
    Géraldine Gebhart
    npj Breast Cancer, 10
  • [48] HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1
    Braso-Maristany, Fara
    Griguolo, Gaia
    Chic, Nuria
    Pascual, Tomas
    Pare, Laia
    Maues, Julia
    Galvan, Patricia
    Dieci, Maria Vittoria
    Miglietta, Federica
    Giarratano, Tommaso
    Martinez-Saez, Olga
    Marin-Aguilera, Mercedes
    Schettini, Francesco
    Conte, Benedetta
    Angelats, Laura
    Vidal, Maria
    Adamo, Barbara
    Munoz, Montserrat
    Sanfeliu, Esther
    Gonzalez, Blanca
    Vivancos, Ana
    Villagrasa, Patricia
    Parker, Joel S.
    Perou, Charles M.
    Conte, PierFranco
    Prat, Aleix
    Guarneri, Valentina
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (03): : 332 - 336
  • [49] Trastuzumab Emtansine (T-DM1): No radiosensitizing effect in vitro on HER2-positive breast cancer cells (study in vitro)
    Mignot, Fabien
    Kirova, Youlia
    Verrelle, Pierre
    Teulade-Fichou, Marie-Paule
    Megnin-Chanet, Frederique
    CANCER RESEARCH, 2020, 80 (04)
  • [50] Preliminary experience of the concurrent use of radiosurgery and T-DM1 for brain metastases in HER2-positive metastatic breast cancer
    Geraud, Arthur
    Xu, Hao Ping
    Beuzeboc, Philippe
    Kirova, Youlia M.
    JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (01) : 69 - 72
12345